Author:
Garnham Andy,Bruon Franck,Berthon Céline,Lebon Delphine,Parimi Mounika,Polya Rosalind,Makhloufi Kahina M.,Dramard-Goasdoue Marie-Hélène
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392(10147):593–606.
2. Le Guyader-Peyrou S, Defossez G, Dantony E et al. National estimates of cancer incidence and mortality in metropolitan France between 1990 and 2018. Volume 2 - malignant haemopathies. Study from cancer registers of the Francim network. Saint-Maurice (Fra): Public Health France, 2019. 169 p. https://www.registre-cancers-44-85.fr/recherche-epidemiologique/nos-dernieres-publications/. Accessed 19 July 2023.
3. Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–52.
4. Small D, Levenstein M, Kim E, et al. STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci U S A. 1994;91(2):459–63.
5. Daver N, Schlenk RF, Russell NH, Levis MJ. Targeting FLT3 mutations in AML: review of current knowledge and evidence. Leukemia. 2019;33(2):299–312.